Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
03 Março 2025 - 9:07PM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Amendment No. 32 to Schedule 13D, dated March 3, 2025, relating to the Common Stock, par value $0.01 per share, of STAAR Surgical
Company shall be filed on behalf of the undersigned.
| Dated: March 3, 2025 |
Broadwood Partners, L.P.
|
| |
By: |
Broadwood Capital, Inc. |
| |
|
| |
By: |
/s/ Neal C. Bradsher |
| |
Name: |
Neal C. Bradsher |
| |
Title: |
President |
| |
|
|
| |
|
|
| |
Broadwood Capital, Inc. |
| |
|
| |
By: |
/s/ Neal C. Bradsher |
| |
Name: |
Neal C. Bradsher |
| |
Title: |
President |
| |
|
|
| |
|
|
| |
/s/ Neal C. Bradsher |
| |
Neal C. Bradsher |
Exhibit B
Schedule of Transactions in the Shares
| Trade Date |
Purchase/Sale/Gift |
Quantity |
Price ($) |
| 1/14/25 |
Purchase |
21,155 |
$21.4647 (1) |
| 1/16/25 |
Purchase |
8,221 |
$21.5002 (2) |
| 2/12/25 |
Purchase |
82,730 |
$13.9853 (3) |
| 2/12/25 |
Purchase |
72,017 |
$14.899 (4) |
| 2/12/25 |
Purchase |
104,869 |
$15.7651 (5) |
| 2/13/25 |
Purchase |
115,282 |
$15.8352 (6) |
| 2/14/25 |
Purchase |
36,532 |
$15.4932 (7) |
| 2/27/25 |
Purchase |
114,713 |
$16.4415 (8) |
| 2/27/25 |
Purchase |
144,603 |
$17.5242 (9) |
| 2/28/25 |
Purchase |
153,142 |
$17.4469 (10) |
| 2/28/25 |
Purchase |
1,800 |
$17.99 (11) |
| 3/3/25 |
Purchase |
230,529 |
$16.5726 (12) |
| 3/3/25 |
Purchase |
18,974 |
$17.4317 (13) |
| (1) | This constitutes the weighted average purchase price. The prices range from $21.21 to $21.59. The Reporting
Person will provide upon request by the Securities and Exchange Commission staff (the “SEC Staff”), the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| (2) | This constitutes the weighted average purchase price. The prices range from $21.25 to $21.59. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (3) | This constitutes the weighted average purchase price. The prices range from $13.50 to $14.495. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (4) | This constitutes the weighted average purchase price. The prices range from $14.50 to $15.42. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (5) | This constitutes the weighted average purchase price. The prices range from $15.50 to $15.99. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (6) | This constitutes the weighted average purchase price. The prices range from $15.605 to $15.99. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (7) | This constitutes the weighted average purchase price. The prices range from $15.23 to $15.96. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (8) | This constitutes the weighted average purchase price. The prices range from $16.00 to $16.99. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (9) | This constitutes the weighted average purchase price. The prices range from $17.00 to $17.79. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (10) | This constitutes the weighted average purchase price. The prices range from $16.94 to $17.93. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (11) | This constitutes the weighted average purchase price. The prices range from $17.94 to $18.195. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (12) | This constitutes the weighted average purchase price. The prices range from $16.31 to $17.3050. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
| (13) | This constitutes the weighted average purchase price. The prices range from $17.31 to $17.65. The Reporting
Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number
of shares purchased at each separate price. |
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
